<DOC>
	<DOCNO>NCT00245583</DOCNO>
	<brief_summary>This study ass efficacy topiramate treatment pathological gambling . Pathological gambling ( PG ) debilitate disorder , generally lead severe personal , familial , financial , social , occupational impairment . In PG , patient experience progressive inability resist impulse gamble , gamble significantly disrupt patient 's functioning personal , familial , and/or vocational sphere . Topiramate show preliminary evidence efficacy impulse control disorder .</brief_summary>
	<brief_title>Topiramate Treatment Pathological Gambling</brief_title>
	<detailed_description>This 14-week , outpatient , multicenter , randomize , double-blind , placebo-controlled , flexible-dose study topiramate subject pathological gambling . After give informed consent , subject meet inclusion exclusion criterion may enrol . The study consist three phase : - Washout/Screening Phase ( 28 day prior randomization longer medication require longer washout period ; - Double-Blind Phase ( Titration : 6 week ; Maintenance : 8 week ) ; - Taper Phase ( approximately 1 week ) . The study medication titrate 300 mg/day subject 's maximum tolerate dose ( MTD ) . Subjects must reach minimum dose 50 mg/day Week 2 . The taper phase last approximately one week subject gradually reduce medication longer take study medication . Patient may also give optional blood sample pharmacogenomic testing</detailed_description>
	<mesh_term>Gambling</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Subjects must current DSMVIVTRTM diagnosis pathological gambling support Structured Clinical Interview Pathological Gambling ( SCIPG ) . Subjects must severity score ³ 4 ( moderately ill ) Clinical Global Impressions Scale Severity ( CGIS ) Visit 1A ( Day 28 ) . Subjects must severity score ³5 South Oaks Gambling Screen ( SOGS ) Visit 1B ( Day 7 ) . Subjects must score ³2 item number 1 Gambling Symptom Assessment Scale ( GSAS ) Visit 1B ( Day 7 ) Visit 2 ( Day 1 ) . Subjects must minimum score &gt; 10 obsession subscale ( question 15 ) Pathological Gambling Yale Brown Obsessive Compulsive Scale ( PGYBOC ) Visits 1B ( Day 7 ) 2 ( Day 1 ) . Subjects must score ≤15 Young Mania Rating Scale ( YMRS ) Visits 1B ( Day 7 ) 2 ( Day 1 ) . Subjects must 18 70 year age , inclusive . Subjects must provide contact information use site case miss appointment . Subjects may male female must generally good health confirm medical history physical examination , laboratory test vital sign . Female subject must : postmenopausal least one year , surgically sterile , practice effective method birth control ( e.g. , oral contraceptive , contraceptive injection , intrauterine device , spermicide barrier , contraceptive patch , contraceptive vaginal ring , male partner sterilization , abstinence agree continue abstinence use acceptable method contraception , list , sexual activity commence ) entry throughout study ; negative urine pregnancy test Visits 1B ( Day 7 ) 2 ( Day 1 ) . 11 . Subjects must able take oral medication , adhere medication regimens willing return regular visit . 12 . Subjects must able willing read write instruction complete scale inventory require protocol . 13 . Subjects must sign informed consent form indicate understand purpose procedure require study willing participate . 1 . Subjects current Axis I psychiatric disorder define DSMIVTRä support SCIDI/P , pathological gambling , investigator 's judgment might require intervention either pharmacological nonpharmacological therapy course study . 2 . Subjects history personality disorder ( e.g. , schizotypal borderline ) consider investigator likely interfere assessment compliance treatment . 3 . Subjects current recent ( within 3 month Visit 2 , Day 1 ) DSMIVTRTM diagnosis substance abuse dependence , exception nicotine caffeine abuse dependence . 4 . Subjects receive formal psychotherapy pathological gambling ( exception Gamblers Anonymous ) within 4 week prior Visit 1B ( Day 7 ) . Note : Formal psychotherapy define behavioral therapy , cognitive therapy , cognitivebehavioral therapy , psychoanalysis , etc . treatment clinical diagnosis healthcare professional billing therapy . 5 . Subjects begin receive formal psychotherapy psychiatric disorder , pathological gambling , within 3 month prior Visit 1B ( Day 7 ) . Note : Subjects engage formal psychotherapy condition pathological gamble &gt; 3 month plan maintain therapy throughout study consider casebycase basis . 6 . Subjects score &gt; 24 MontgomeryAsberg Depression Rating Scale ( MADRS ) Visit 1B ( Day 7 ) Visit 2 ( Day 1 ) . 7 . Subjects expect stay restrict environment . 8 . Subjects take prohibited medication describe Concomitant Therapy section protocol meet washout criterion specify Attachment 15 . 9 . Subjects positive urine drug screen [ benzodiazepine , phencyclidine , cocaine , amphetamine , tetrahydrocannabinol ( THC ) , opiates ] Visit 1B ( Day 7 ) . Note : Subjects positive urine drug screen THC may retested 7 day enrol ) continue meet inclusion/exclusion criterion b ) negative urine drug screen upon retest . 10 . Subjects pregnant lactating . 11 . Subjects member household . 12 . Subjects history nephrolithiasis . 13 . Subjects know clinically significant medical condition , include limited : symptomatic coronary artery disease peripheral vascular disease ; malignancy history malignancy within past 5 year ( except basal cell carcinoma ) ; renal disease and/or impair renal function define subject estimate creatinine clearance £60 mL/min ; diseases gastrointestinal system include active liver disease ; subject AST and/or ALT &gt; 2 time upper limit normal range and/or increase serum bilirubin &gt; 2.0 mg/dL Visit 1B ( Day 7 ) ; Note : value abnormal retested prior enrollment . If repeat study within limit protocol subject may randomize . pulmonary disorder include subject active tuberculosis ; endocrinological disorder ; neurological disorder include subject seizure disorder subject progressive degenerative neurological disorder ( e.g. , multiple sclerosis ) ; disease condition compromise function body system could result altered absorption , excess accumulation , impaired metabolism excretion topiramate . 14 . Subjects previously treat topiramate reason discontinue treatment due adverse event hypersensitivity reaction topiramate . 15 . Subjects prior nonresponse topiramate treatment pathological gamble follow adequate trial . 16 . Subjects opinion investigator enrol study precaution , warning contraindication outline topiramate investigator brochure and/or package insert . 17 . Employees investigator study center , direct involvement propose study study direction investigator study center , well family member investigator study center employee .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Pathological Gambling</keyword>
	<keyword>Compulsive Gambling</keyword>
	<keyword>Gambling</keyword>
	<keyword>topiramate</keyword>
</DOC>